The importance of DHEAS as a precursor for androstenediol was shown by its ability to stimulate the proliferation of breast cancer cells, which could be blocked with an anti-oestrogen or STS inhibitor, but not an AI [6]. This evidence concerns the gene STS and breast carcinoma.